New report shows cost of big drug companies’ patent abuse
A new report from The Coalition for Affordable Prescription Drugs (CAPD) and conducted by Matrix Global Advisors (MGA) found the yearly cost of big drug companies’ patent thickets on five top-selling prescription drugs ranges from $1.8 to $7.6 billion each. The study highlights that “many companies delay or block more affordable competitors from entering the market for far
